Literature DB >> 31809679

Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study.

Christopher M Shea1, Alex K Gertner1, Sherri L Green1.   

Abstract

BACKGROUND: Medication treatment for opioid use disorder (M-OUD) is underutilized, despite research demonstrating its effectiveness in treating opioid use disorder (OUD). The UNC Extension for Community Healthcare Outcomes for Rural Primary Care Medication Assisted Treatment (UNC ECHO for MAT) project was designed to evaluate interventions for reducing barriers to delivery of M-OUD by rural primary care providers in North Carolina. A key element was tele-conferenced sessions based on the University of New Mexico Project ECHO model, comprised of case discussions and didactic presentations using a "hub and spoke" model, with expert team members at the hub site and community-based providers participating from their offices (i.e., spoke sites). Although federal funders have promoted use of the model, barriers for providers to participate in ECHO sessions are not well documented.
Methods: UNC ECHO for MAT included ECHO sessions, provider-to-provider consultations, and practice coaching. We conducted 20 semi-structured interviews to assess perceived usefulness of the UNC ECHO for MAT intervention, barriers to participation in the intervention, and persistent barriers to prescribing M-OUD.
Results: Participants were generally satisfied with ECHO sessions and provider-to-provider consultations; however, perceived value of practice support was less clear. Primary barriers to participating in ECHO sessions were timing and length of sessions. Participants recommended recording ECHO sessions for viewing later, and some thought incentives for either the practice or provider could facilitate participation. Providers who had participated in ECHO sessions valued the expertise on the expert team; the team's ability to develop a supportive, collegial environment; and the value of a community of providers interested in learning from each other, particularly through case discussions. Conclusions: Despite the perceived value of ECHO, barriers may prevent consistent participation. Also, barriers to M-OUD delivery remain, including some that ECHO alone cannot address, such as Medicaid and private-insurer policies and availability of psychosocial resources.

Entities:  

Keywords:  ECHO; Primary health care; implementation barriers; medication assisted treatment; opioid use disorder

Mesh:

Substances:

Year:  2019        PMID: 31809679      PMCID: PMC7274853          DOI: 10.1080/08897077.2019.1694617

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  18 in total

1.  Barriers to primary care physicians prescribing buprenorphine.

Authors:  Eliza Hutchinson; Mary Catlin; C Holly A Andrilla; Laura-Mae Baldwin; Roger A Rosenblatt
Journal:  Ann Fam Med       Date:  2014 Mar-Apr       Impact factor: 5.166

2.  Geographic and specialty distribution of US physicians trained to treat opioid use disorder.

Authors:  Roger A Rosenblatt; C Holly A Andrilla; Mary Catlin; Eric H Larson
Journal:  Ann Fam Med       Date:  2015 Jan-Feb       Impact factor: 5.166

3.  The Impact of Project ECHO on Participant and Patient Outcomes: A Systematic Review.

Authors:  Carrol Zhou; Allison Crawford; Eva Serhal; Paul Kurdyak; Sanjeev Sockalingam
Journal:  Acad Med       Date:  2016-10       Impact factor: 6.893

4.  Project ECHO Telementoring Intervention for Managing Chronic Pain in Primary Care: Insights from a Qualitative Study.

Authors:  Leslie Carlin; Jane Zhao; Ruth Dubin; Paul Taenzer; Hannah Sidrak; Andrea Furlan
Journal:  Pain Med       Date:  2018-06-01       Impact factor: 3.750

5.  Why aren't physicians prescribing more buprenorphine?

Authors:  Andrew S Huhn; Kelly E Dunn
Journal:  J Subst Abuse Treat       Date:  2017-04-12

6.  Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists.

Authors:  Cindy Parks Thomas; Sharon Reif; Sayeda Haq; Stanley S Wallack; Alexander Hoyt; Grant A Ritter
Journal:  Psychiatr Serv       Date:  2008-08       Impact factor: 3.084

7.  Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment.

Authors:  Bradley D Stein; Mark Sorbero; Andrew W Dick; Rosalie Liccardo Pacula; Rachel M Burns; Adam J Gordon
Journal:  JAMA       Date:  2016-09-20       Impact factor: 56.272

8.  Office-based management of opioid dependence with buprenorphine: clinical practices and barriers.

Authors:  Alexander Y Walley; Julie K Alperen; Debbie M Cheng; Michael Botticelli; Carolyn Castro-Donlan; Jeffrey H Samet; Daniel P Alford
Journal:  J Gen Intern Med       Date:  2008-09       Impact factor: 5.128

9.  Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.

Authors:  C Holly A Andrilla; Cynthia Coulthard; Davis G Patterson
Journal:  Am J Prev Med       Date:  2018-06       Impact factor: 5.043

10.  Factors affecting willingness to provide buprenorphine treatment.

Authors:  Julie Netherland; Michael Botsko; James E Egan; Andrew J Saxon; Chinazo O Cunningham; Ruth Finkelstein; Mark N Gourevitch; John A Renner; Nancy Sohler; Lynn E Sullivan; Linda Weiss; David A Fiellin
Journal:  J Subst Abuse Treat       Date:  2008-08-20
View more
  10 in total

1.  Increasing Capacity for Treatment of Opioid Use Disorder in Rural Primary Care Practices.

Authors:  Linda Zittleman; Kristen Curcija; Donald E Nease; Mary Fisher; L Miriam Dickinson; John F Thomas; Ashley Espinoza; Christin Sutter; Jennifer Ancona; Jodi Summers Holtrop; John M Westfall
Journal:  Ann Fam Med       Date:  2022 Jan-Feb       Impact factor: 5.166

2.  Nudging primary care providers to expand the opioid use disorder workforce.

Authors:  Marisa Elena Domino; Sean Sylvia; Sherri Green
Journal:  Health Serv Res       Date:  2021-11-07       Impact factor: 3.402

3.  Experiences and perceptions of nurses participating in an interprofessional, videoconference-based educational programme on concurrent mental health and substance use disorders: a qualitative study.

Authors:  Gabrielle Chicoine; José Côté; Jacinthe Pepin; Louise Boyer; Geneviève Rouleau; Didier Jutras-Aswad
Journal:  BMC Nurs       Date:  2022-07-04

4.  Primary Care Providers And Specialists Deliver Comparable Buprenorphine Treatment Quality.

Authors:  Alex K Gertner; Allison G Robertson; Byron J Powell; Hendree Jones; Pam Silberman; Marisa Elena Domino
Journal:  Health Aff (Millwood)       Date:  2020-08       Impact factor: 6.301

Review 5.  Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review.

Authors:  Katherine Mackey; Stephanie Veazie; Johanna Anderson; Donald Bourne; Kim Peterson
Journal:  J Gen Intern Med       Date:  2020-11-03       Impact factor: 5.128

6.  The Role of Primary Care in the Initiation of Opioid Use Disorder Treatment in Statewide Public and Private Insurance.

Authors:  Alex K Gertner; Jason S Rotter; Margaret E Holly; Christopher M Shea; Sherri L Green; Marisa Elena Domino
Journal:  J Addict Med       Date:  2022 Mar-Apr 01       Impact factor: 3.702

7.  Buprenorphine prescriber monthly patient caseloads: An examination of 6-year trajectories.

Authors:  Irineo Cabreros; Beth Ann Griffin; Brendan Saloner; Adam J Gordon; Rose Kerber; Bradley D Stein
Journal:  Drug Alcohol Depend       Date:  2021-09-22       Impact factor: 4.492

8.  Building Capacity for Medication Assisted Treatment in Rural Primary Care Practices: The IT MATTTRs Practice Team Training.

Authors:  Linda Zittleman; Kristen Curcija; Christin Sutter; L Miriam Dickinson; John Thomas; Dionisia de la Cerda; Donald E Nease; John M Westfall
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

9.  Barriers and Facilitators to Implementing Project ECHO in Malaysia During the COVID-19 Pandemic.

Authors:  Suzan M Walters; Wong Pui Li; Rumana Saifi; Iskandar Azwa; Sharifah Faridah Syed Omar; Zachary K Collier; Asfarina Binti Amir Hassan; Marwan S Haddad; Frederick L Altice; Adeeba Kamarulzaman; Valerie A Earnshaw
Journal:  J Int Assoc Provid AIDS Care       Date:  2022 Jan-Dec

Review 10.  Financial sustainability of payment models for office-based opioid treatment in outpatient clinics.

Authors:  Dominic Hodgkin; Constance Horgan; Gavin Bart
Journal:  Addict Sci Clin Pract       Date:  2021-07-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.